Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bernstein

Showing results (51-60 of 141) with videos related to

Pageof 15
Sort By:
Hepatology (Baltimore, Md.)|March 1, 2002
Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patientsDavid Bernstein, Leah Kleinman, Chris M Barker, et al.
Journal of the American Academy of Dermatology|March 29, 2003
Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trialEugene Monroe, Albert Finn, Piyush Patel, et al.
The Journal of Allergy and Clinical Immunology|January 26, 2022
Which patients with asthma are most likely to benefit from allergen immunotherapy?Frédéric de Blay, Alina Gherasim, Tomas B Casale, et al.
Alimentary Pharmacology & Therapeutics|August 20, 2020
Review article: a treatment algorithm for patients with chronic liver disease and severe thrombocytopenia undergoing elective medical procedures in the United StatesDouglas T Dieterich, David Bernstein, Steven Flamm, et al.
Developmental Cell|November 5, 2004
FBF-1 and FBF-2 regulate the size of the mitotic region in the C. elegans germlineLiana B Lamont, Sarah L Crittenden, David Bernstein, et al.
The Journal of Hand Surgery Asian-Pacific Volume|November 18, 2021
PROMIS Measures in Patients with Ganglion Cysts: Who Chooses Surgical Excision Over Non-Operative Management?Trevor Hansen, Nathan C Patrick, David Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 28, 2022
Dose Adjustment After Gaps in Administration of Subcutaneous Immunotherapy From a Past Survey: Work Group Report of the AAAAI Allergen Standardization and Allergy Diagnostics CommitteeDésirée Larenas-Linnemann, Punita Ponda, Peter Creticos, et al.
European Journal of Gastroenterology & Hepatology|December 5, 2022
Pharmacotherapeutic efficacy on noninvasive fibrosis progression in nonalcoholic fatty liver disease: a systematic review and network meta-analysisAlexander J Kovalic, Martin Gozar, Ben L Da, et al.
Behaviour Research and Therapy|June 20, 2013
Short-term group schema cognitive-behavioral therapy for young adults with personality disorders and personality disorder features: associations with changes in symptomatic distress, schemas, schema modes and coping stylesFritz Renner, Michiel van Goor, Marcus Huibers, et al.
Chest|April 13, 2006
Atopy as a risk factor for habitual snoring at age 1 yearManinder Kalra, Grace Lemasters, David Bernstein, et al.
Pageof 15

Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
Hepatology (Baltimore, Md.)|March 1, 2002
Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patientsDavid Bernstein, Leah Kleinman, Chris M Barker, et al.
Journal of the American Academy of Dermatology|March 29, 2003
Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trialEugene Monroe, Albert Finn, Piyush Patel, et al.
The Journal of Allergy and Clinical Immunology|January 26, 2022
Which patients with asthma are most likely to benefit from allergen immunotherapy?Frédéric de Blay, Alina Gherasim, Tomas B Casale, et al.
Alimentary Pharmacology & Therapeutics|August 20, 2020
Review article: a treatment algorithm for patients with chronic liver disease and severe thrombocytopenia undergoing elective medical procedures in the United StatesDouglas T Dieterich, David Bernstein, Steven Flamm, et al.
Developmental Cell|November 5, 2004
FBF-1 and FBF-2 regulate the size of the mitotic region in the C. elegans germlineLiana B Lamont, Sarah L Crittenden, David Bernstein, et al.
The Journal of Hand Surgery Asian-Pacific Volume|November 18, 2021
PROMIS Measures in Patients with Ganglion Cysts: Who Chooses Surgical Excision Over Non-Operative Management?Trevor Hansen, Nathan C Patrick, David Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 28, 2022
Dose Adjustment After Gaps in Administration of Subcutaneous Immunotherapy From a Past Survey: Work Group Report of the AAAAI Allergen Standardization and Allergy Diagnostics CommitteeDésirée Larenas-Linnemann, Punita Ponda, Peter Creticos, et al.
European Journal of Gastroenterology & Hepatology|December 5, 2022
Pharmacotherapeutic efficacy on noninvasive fibrosis progression in nonalcoholic fatty liver disease: a systematic review and network meta-analysisAlexander J Kovalic, Martin Gozar, Ben L Da, et al.
Behaviour Research and Therapy|June 20, 2013
Short-term group schema cognitive-behavioral therapy for young adults with personality disorders and personality disorder features: associations with changes in symptomatic distress, schemas, schema modes and coping stylesFritz Renner, Michiel van Goor, Marcus Huibers, et al.
Chest|April 13, 2006
Atopy as a risk factor for habitual snoring at age 1 yearManinder Kalra, Grace Lemasters, David Bernstein, et al.
Pageof 15